Biotech stocks are high risk and high reward. Biotech stocks have been in the decline for the past several months and they have been declined by more than 50% or so. Let’s just constrain our topic to Amarin. To answer your question, the current environment is not so good to invest in biotech sector. However, your question is irrelevant because majority of the stock holders who post here are in Amarin for a long time. If I could re do it, I could had sold it when it was high OR I could had sold it when it was coming down from $23. Anyway, I want to see this company sold regardless of how bad/good the current environment for bio sector. I don’t want to see this current management burn through all the reserve cash to build the infrastructure in Europe with just single drug in hand. It all goes down to economics 101. Apparently, this company is not run by logic and reasoning.
All I want to see that the management announces that they are working with an investment banking firm and that news will start to drive the price up to $5-6 range and get a buyout of $10-12 and call it a day. Of course, it all sounds so easy and I know it Is not going to happen. Hopefully, Denner has plan to rescue all of us.
News 
Market Data 
Discover 
AI
